SELLAS Life Sciences
SLS

股本结构

单位：万股
公告日期 2025-11-12 2025-11-12 2025-09-11 2025-08-12 2025-08-12 2025-05-13
证券总股本 14244.22 12507.85 12498.25 10529.75 10036.71 9977.75
普通股本 14244.22 12507.85 12498.25 10529.75 10036.71 9977.75
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-11-11 2025-09-30 2025-09-12 2025-08-11 2025-06-30 2025-05-12
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2025-11-12 14244.22 未披露 定期报告 2025-11-11
2025-11-12 12507.85 未披露
更多>>
From June 30,2025 to September 30,2025 Issuance of common stock upon warrant inducement, net of issuance costs Issuance of common stock upon the exercise of warrants Issuance of common stock under employee stock purchase plan
2025-09-30
2025-09-11 12498.25 未披露
更多>>
The company exercise of warrants to purchase up to 19,685,040 shares of its common stock
2025-09-12
2025-08-12 10529.75 未披露 定期报告 2025-08-11
2025-08-12 10036.71 未披露
更多>>
From March 31, 2025 to June 30, 2025 Issuance of common stock upon the exercise of pre-funded warrants Issuance of common stock upon the exercise of warrants
2025-06-30
2025-05-13 9977.75 未披露 定期报告 2025-05-12
2025-04-23 9454.84 未披露 定期报告 2025-04-17
2025-05-13 9089.61 未披露
更多>>
From December 31, 2024 to March 31, 2025 Issuance of common stock, common stock warrants, and pre-funded warrants, net of issuance costs Issuance of common stock upon the exercise of pre-funded warrants Issuance of common stock upon the exercise of warrants Issuance of common stock under employee stock purchase plan
2025-03-31
2025-03-20 9084.67 未披露 定期报告 2025-03-19
2025-01-29 7858.20 未披露
更多>>
Common stock offered 8,200,000 shares of common stock by the company
2025-01-29
2025-03-20 7397.75 未披露
更多>>
From December 31, 2023 to December 31, 2024 Issuance of common stock, common stock warrants, and pre-funded warrants, net of issuance costs Issuance of common stock upon the exercise of pre-funded warrants Issuance of common stock upon the exercise of warrants Issuance of common stock under employee stock purchase plan Vesting of restricted stock units Tax withholding on vesting of restricted stock units
2024-12-31
2024-11-13 7038.20 未披露 定期报告 2024-11-12
2024-11-13 6438.20 未披露
更多>>
From June 30, 2024 to September 30, 2024 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock upon the exercise of warrants Issuance of common stock under employee stock purchase plan
2024-09-30
2024-08-13 6433.25 未披露 定期报告 2024-08-12
2024-08-01 6263.77 未披露
更多>>
Common stock offered 6,370,070 shares by the company
2024-08-01
2024-08-13 5775.49 未披露
更多>>
From March 31, 2024 to June 30, 2024 Issuance of common stock upon the exercise of pre-funded warrants Issuance of common stock upon the exercise of warrants
2024-06-30
2024-04-29 5775.49 未披露 定期报告 2024-04-25
2024-05-14 5626.77 未披露
更多>>
From December 31, 2023 to March 31, 2024 Issuance of common stock upon the exercise of warrants Issuance of common stock under employee stock purchase plan Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock upon the exercise of pre-funded warrants
2024-03-31
2024-03-28 5626.77 未披露 定期报告 2024-03-25
2024-03-18 5514.61 未披露
更多>>
Common stock offered 11,000,000 shares by the company
2024-03-19
2024-03-18 4414.61 未披露 定期报告 2024-03-15
2024-01-05 4219.23 未披露
更多>>
Common stock offered 10,130,000 shares by the company
2024-01-08
2024-03-28 3213.29 未披露
更多>>
From December 31, 2022 to December 31, 2023 Issuance of common stock, net of issuance costs Issuance of common stock upon the exercise of pre-funded warrants Vesting of restricted stock units Tax withholding on vesting of restricted stock units Issuance of common stock upon the exercise of warrants Issuance of common stock under employee stock purchase plan Issuance of common stock and common stock warrants, net of issuance costs
2023-12-31
2023-11-09 3206.23 未披露 定期报告 2023-11-08
2023-11-01 3144.79 未披露
更多>>
Common stock offered 3,100,000 shares by the company
2023-11-02
2023-11-09 2839.40 未披露
更多>>
From June 30, 2023 to September 30, 2023 Issuance of common stock under employee stock purchase plan
2023-09-30
2023-05-11 2834.79 未披露
更多>>
From December 31, 2022 to March 31, 2023 Issuance of common stock, net of issuance costs Issuance of common stock under employee stock purchase plan Issuance of common stock and common stock warrants, net of issuance costs
2023-03-31
2023-03-16 2830.25 未披露 定期报告 2023-03-15
2023-02-24 2780.85 未披露
更多>>
Common stock offered 7,220,217 shares by the company
2023-02-28
2023-03-16 2100.54 未披露
更多>>
From December 31, 2021 to December 31, 2022 Issuance of common stock, net of issuance costs Issuance of common stock under employee stock purchase plan Issuance of common stock and common stock warrants, net of issuance costs Vesting of restricted stock units
2022-12-31
2022-11-14 2058.82 未披露
更多>>
From June 30, 2022 to September 30, 2022 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock under employee stock purchase plan
2022-09-30
2022-08-11 2055.19 未披露
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock and common stock warrants, net of issuance costs
2022-06-30
2022-04-25 2053.56 未披露 定期报告 2022-04-13
2022-04-05 2052.53 未披露
更多>>
1.Common stock offered by 4,629,630 shares of common stock. 2.The number of shares of common stock to be outstanding after this offering set forth above is based on 15,895,637 shares of common stock outstanding as of December 31, 2021.
2022-04-05
2022-05-12 1590.60 未披露
更多>>
From December 31, 2021 to March 31, 2022 Issuance of common stock under employee stock purchase plan
2022-03-31
2022-03-31 1590.60 未披露 定期报告 2022-03-30
2022-03-31 1589.56 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock, net of issuance costs Issuance of common stock for exercise of warrants Vesting of restricted stock units
2021-12-31
2021-11-12 1588.55 未披露 定期报告 2021-11-11
2021-11-12 1587.41 未披露
更多>>
From June 30, 2021 to September 30, 2021 Issuance of common stock upon exercise of warrants
2021-09-30
2021-08-12 1587.39 未披露
更多>>
From March 31, 2021 to June 30, 2021 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock upon exercise of warrants, net of offering costs
2021-06-30
2021-05-13 1508.48 未披露
更多>>
From December 31, 2020 To March 31, 2021 Issuance of common stock upon exercise of warrants
2021-03-31
2021-03-23 1508.48 未披露 定期报告 2021-03-22
2021-03-23 1425.46 未披露
更多>>
from December 31, 2019 to December 31, 2020 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock for exercise of warrants, net of offering costs Issuance of common stock upon exercise of pre-funded warrants
2020-12-31
2020-12-16 1178.20 未披露
更多>>
1.Common Stock offered 2,320,000 shares. 2.The number of shares of Common Stock that will be outstanding after this offering is based on 9,461,978 shares of Common Stock outstanding as of September 30, 2020.
2020-12-16
2020-11-13 946.20 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issuance of common stock and common stock warrants, net of issuance costs
2020-09-30
2020-08-13 946.20 未披露 定期报告 2020-08-13
2020-05-14 671.79 未披露
更多>>
From December 31, 2019 to March 13, 2020 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock upon exercise of pre-funded warrants
2020-03-13
2020-03-13 508.01 未披露
更多>>
from December 31, 2018 to December 31, 2019 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock for exercise of warrants, net of offering costs Issuance of common stock upon exercise of pre-funded warrants Issuance of common stock upon vesting of restricted stock units
2019-12-31
2019-11-14 487.19 未披露 定期报告 2019-11-14
2019-11-14 454.92 未披露
更多>>
from June 30, 2019 to November 8, 2019 Issuance of common stock upon exercise of warrants, net of offering costs Issuance of common stock upon exercise of pre-funded warrants Issuance of common stock upon vesting of restricted stock units. Trading of the Company’s common stock on The Nasdaq Capital Market will continue, on a split-adjusted basis, with the opening of the markets on Friday, November 8, 2019, under the existing ticker symbol “SLS” but with a new CUSIP number 81642T 209. The reverse stock split reduces the number of shares of the Company’s common stock outstanding from approximately 228 million pre-reverse split shares to approximately 4.6 million post-reverse split shares.
2019-11-08
2019-09-20 22780.01 未披露 定期报告 2019-09-16
2019-08-14 22654.47 未披露 定期报告 2019-08-14
2019-07-18 22599.26 未披露 定期报告 2019-07-17
2019-08-05 21009.27 未披露 定期报告 2019-07-12
2019-08-14 10013.52 未披露
更多>>
from March 31, 2019 to June 30, 2019 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock upon exercise of warrants, net of offering costs Issuance of common stock upon exercise of pre-funded warrants
2019-06-30
2019-06-18 5154.37 未披露 定期报告 2019-06-18
2019-05-15 2517.65 未披露 定期报告 2019-05-15
2019-05-15 2417.65 未披露
更多>>
from December 31, 2018 to March 31, 2019 Issuance of common stock upon exercise of warrants, net of offering costs
2019-03-31
2019-03-22 2317.65 未披露 定期报告 2019-03-21
2019-03-22 2202.65 未披露
更多>>
from December 31, 2017 to December 31, 2018 Issuance of Series A convertible preferred stock, net of offering costs Conversion of Series A convertible preferred stock Issuance of common stock to Series A convertible preferred stockholders under most favored nation provision Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock upon exercise of pre-funded warrants Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with litigation settlements Issuance of common stock upon conversion of promissory notes Issuance of common stock in connection with warrant exchange agreements
2018-12-31
2018-11-14 2202.65 未披露 定期报告 2018-11-09
2018-11-14 2050.15 未披露
更多>>
from December 31, 2017 to September 30, 2018 Issuance of Series A convertible preferred stock, net of offering costs Conversion of Series A convertible preferred stock Issuance of common stock to Series A convertible preferred stockholders under most favored nation provision Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with litigation settlements Issuance of common stock upon conversion of promissory notes Issuance of common stock in connection with warrant exchange agreements Issuance of common stock upon exercise of pre-funded warrants
2018-09-30
2018-08-14 1957.26 未披露 定期报告 2018-08-10
2018-07-18 1299.94 未披露 定期报告 2018-07-16
2018-08-14 738.35 0.78
更多>>
From December 31, 2017 to June 30, 2018 Issuance of Series A convertible preferred stock, net of offering costs Conversion of Series A Convertible Preferred Stock Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with litigation settlements Issuance of common stock upon conversion of promissory notes Issuance of common stock in connection with warrant exchange agreements
2018-06-30
2018-06-26 677.54 未披露 定期报告 2018-05-31
2018-05-15 665.52 未披露 定期报告 2018-04-30
2018-04-30 658.25 未披露 定期报告 2018-04-20
2018-04-13 657.25 未披露 定期报告 2018-04-06
2018-05-15 615.44 0.60
更多>>
From December 31, 2017 to March 31, 2018 Issuance of Series A convertible preferred stock, net of offering costs Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with warrant exchange agreements
2018-03-31
2018-04-06 605.71 未披露 定期报告 2018-03-21
2018-04-13 576.69 未披露
更多>>
from December 31, 2016 to January 2, 2018 Shares issued in connection with amendments to MSK license Shares issued upon conversion of 2015 Shareholder Notes and accrued interest Sale of common shares to related parties Shares issued in connection with settlement of related party payables Shares issued upon the acceleration of restricted stock units Shares issued upon cancellation of Equilibria restricted stock units Shares issued in connection with acquisition of Galena Shares and common stock warrants issued upon conversion of 2015 Sely Note and accrued interest to Equilibria Shares issued to Equilibria for incentive fee payment in connection with the acquisition of Galena Shares issued to MSK for anti-dilution provisions The number of shares issued in the Merger reflects a 1-for-30 reverse stock split of the Registrant’s common stock that was effected on the Closing Date prior to the Merger (the “Reverse Stock Split”).Immediately after the Merger, on a post-Reverse Stock Split basis, there were approximately 5,766,891 million shares of the Registrant’s common stock outstanding, with the former Private SELLAS securityholders owning approximately 67.5% of the Registrant’s fully diluted common stock, with the Registrant’s securityholders immediately prior to the Merger owning the remaining approximately 32.5%.
2018-01-02
2017-11-09 4571.29 未披露 定期报告 2017-11-09
2017-11-09 4181.60 未披露
更多>>
From December 31, 2016 to September 30, 2017 Issuance of common stock, net of $356 in issuance costs Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with employee stock purchase plan Fair value of common stock issued in exchange for services
2017-09-30
2017-09-22 3862.99 未披露 定期报告 2017-09-22
2017-08-14 3840.51 未披露 定期报告 2017-07-31
2017-08-14 3746.93 未披露
更多>>
From December 31, 2016 to June 30, 2017 Issuance of common stock, net of $356 in issuance costs Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with employee stock purchase plan Fair value of common stock in exchange for services
2017-06-30
2017-04-20 3743.55 未披露 定期报告 2017-04-13
2017-05-10 3714.83 未披露
更多>>
From December 31, 2016 to March 31, 2017 Issuance of common stock, net of $356 in issuance costs Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with employee stock purchase plan Fair value of common stock in exchange for services
2017-03-31
2017-03-15 3592.13 未披露 定期报告 2017-02-28
2017-03-15 1519.05 未披露
更多>>
From December 31, 2015 to December 31, 2016 Issuance of common stock Issuance of common stock to satisfy principal and interest on long-term debt Issuance of common stock in connection with settlement of litigation Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options On October 31, 2016, Galena Biopharma, Inc. approved a reverse stock split of its shares of common stock at a ratio of 1-for-20. The reverse stock split will become effective on November 11, 2016 and the Company’s common stock will commence trading on a split-adjusted basis when the market opens on Monday, November 14, 2016.
2016-12-31
2016-10-31 1085.10 未披露
更多>>
On October 31, 2016, Galena Biopharma, Inc. approved a reverse stock split of its shares of common stock at a ratio of 1-for-20. The reverse stock split will become effective on November 11, 2016 and the Company’s common stock will commence trading on a split-adjusted basis when the market opens on Monday, November 14, 2016.
2016-11-14
2016-11-09 21701.91 未披露 定期报告 2016-10-31
2016-11-09 21450.20 未披露
更多>>
From December 31, 2015 to September 27, 2016 Issuance of common stock Issuance of common stock in connection with litigation settlements Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
2016-09-27
2016-09-21 21448.19 未披露 定期报告 2016-09-09
2016-09-02 21450.20 未披露 定期报告 2016-09-01
2016-08-09 21396.90 未披露 定期报告 2016-07-31
2016-07-25 21084.40 未披露 定期报告 2016-07-22
2016-08-09 18232.14 未披露
更多>>
from December 31, 2015 to June 30, 2016 Issuance of common stock Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
2016-06-30
2016-05-10 18183.71 未披露
更多>>
from December 31, 2015 to March 31, 2016 Issuance of common stock Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
2016-03-31
2016-03-10 18174.66 未披露 定期报告 2016-02-29
2016-03-10 16190.68 未披露
更多>>
from December 31, 2014 to December 31, 2015 Issuance of common stock Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
2015-12-31
2015-11-09 16190.68 未披露 定期报告 2015-10-31
2015-11-09 16190.04 未披露
更多>>
from December 31, 2014 to September 30, 2015 Issuance of common stock Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
2015-09-30
2015-08-06 16171.54 未披露 定期报告 2015-07-31
2015-08-06 16239.14 未披露
更多>>
from December 31, 2014 to June 30, 2015 Issuance of common stock Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
2015-06-30
2015-05-07 16171.54 未披露 定期报告 2015-04-30
2015-04-30 11802.58 未披露 定期报告 2015-04-29
2015-05-07 15806.16 未披露
更多>>
from December 31, 2014 to March 31, 2015 Issuance of common stock Issuance of common stock in connection with employee stock purchase plan
2015-03-31
2015-03-05 13370.26 未披露 定期报告 2015-02-28
2015-03-05 12947.13 未披露
更多>>
from December 31,2013 to December 31,2014 Issuance of common stock Issuance of common stock under milestone achievement Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
2014-12-31
2014-11-05 12145.71 未披露
更多>>
From December 31, 2013 to September 30, 2014 Issuance of common stock for milestone payment Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
2014-09-30
2014-08-11 11820.52 未披露 定期报告 2014-07-31
2014-08-11 11813.77 未披露
更多>>
from December 31, 2013 to June 30, 2014 Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
2014-06-30
2014-05-06 11802.58 未披露
更多>>
From December 31, 2013 to March 31, 2014 Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
2014-03-31
2014-03-17 11787.95 未披露 定期报告 2014-02-28
2014-03-17 10942.57 未披露
更多>>
from December 31,2012 to December 31,2013 Issuance of common stock Issuance of common stock upon exercise of warrants Issuance of common stock in settlement of contingent purchase price consideration Issuance of common stock in exchange for services Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
2013-12-31
2013-11-06 10523.65 未披露 定期报告 2013-10-31
2013-11-06 10491.38 未披露
更多>>
from December 31, 2012 to September 30, 2013 Issuance of common stock Issuance of common stock upon exercise of warrants Issuance of common stock in settlement of contingent purchase price consideration Issuance of common stock in exchange for services Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
2013-09-30
2013-08-09 8443.14 未披露 定期报告 2013-07-31
2013-08-09 8440.83 未披露 定期报告 2013-06-30
2013-05-24 8346.90 未披露 定期报告 2013-05-13
2013-05-09 8346.36 未披露 定期报告 2013-05-02
2013-04-29 8310.47 未披露 定期报告 2013-04-25
2013-05-09 8308.43 未披露 定期报告 2013-03-31
2013-03-12 8306.77 未披露 定期报告 2013-03-11
2013-03-12 8292.08 未披露
更多>>
from December 31, 2011 to December 31, 2012 Issuance of common stock, net of offering costs of $2,869 Issuance of common stock in exchange for services Issuance of common stock upon the exchange and exercise of warrants including reclassification of $10,843 in warrant liability upon exercise Issuance of common stock in connection with employee stock purchase plan Issuance of common stock upon the exercise of employee stock options Issuance of common stock in settlement of contingent purchase price consideration
2012-12-31
2012-11-13 6762.73 未披露 定期报告 2012-11-07
2012-11-13 6760.37 未披露 定期报告 2012-09-30
2012-08-14 6717.88 未披露 定期报告 2012-08-10
2012-08-14 6695.98 未披露 定期报告 2012-06-30
2012-05-14 6564.39 未披露 定期报告 2012-05-11
2012-05-14 4940.71 未披露 定期报告 2012-03-31
2012-03-28 4713.65 未披露
更多>>
from December 31, 2010 to December 31, 2011 Issuance of stock in lieu of cash bonus Issuance of restricted stock units Issuance of common stock for services Issuance of common stock upon exercise of warrants Issuance of common stock in cashless exchange of outstanding warrants Issuance of common stock related to acquisition of Apthera, Inc Issuance of common stock subject to employee termination agreements Issuance of common stock in connection with employee stock purchase plan
2011-12-31
2011-11-14 4298.55 未披露 定期报告 2011-09-30
2011-08-15 4198.68 未披露 定期报告 2011-08-11
2011-08-15 4183.68 未披露 定期报告 2011-06-30
2011-05-16 4171.82 未披露 定期报告 2011-05-13
2011-04-15 2499.54 未披露 定期报告 2011-04-14
2011-05-16 2479.41 未披露 定期报告 2011-03-31
2010-05-17 1837.28 未披露 定期报告 2010-05-15
2010-05-17 1835.83 未披露 定期报告 2010-03-31
From June 30,2025 to September 30,2025 Issuance of common stock upon warrant inducement, net of issuance costs Issuance of common stock upon the exercise of warrants Issuance of common stock under employee stock purchase plan
The company exercise of warrants to purchase up to 19,685,040 shares of its common stock
From March 31, 2025 to June 30, 2025 Issuance of common stock upon the exercise of pre-funded warrants Issuance of common stock upon the exercise of warrants
From December 31, 2024 to March 31, 2025 Issuance of common stock, common stock warrants, and pre-funded warrants, net of issuance costs Issuance of common stock upon the exercise of pre-funded warrants Issuance of common stock upon the exercise of warrants Issuance of common stock under employee stock purchase plan
Common stock offered 8,200,000 shares of common stock by the company
From December 31, 2023 to December 31, 2024 Issuance of common stock, common stock warrants, and pre-funded warrants, net of issuance costs Issuance of common stock upon the exercise of pre-funded warrants Issuance of common stock upon the exercise of warrants Issuance of common stock under employee stock purchase plan Vesting of restricted stock units Tax withholding on vesting of restricted stock units
From June 30, 2024 to September 30, 2024 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock upon the exercise of warrants Issuance of common stock under employee stock purchase plan
Common stock offered 6,370,070 shares by the company
From March 31, 2024 to June 30, 2024 Issuance of common stock upon the exercise of pre-funded warrants Issuance of common stock upon the exercise of warrants
From December 31, 2023 to March 31, 2024 Issuance of common stock upon the exercise of warrants Issuance of common stock under employee stock purchase plan Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock upon the exercise of pre-funded warrants
Common stock offered 11,000,000 shares by the company
Common stock offered 10,130,000 shares by the company
From December 31, 2022 to December 31, 2023 Issuance of common stock, net of issuance costs Issuance of common stock upon the exercise of pre-funded warrants Vesting of restricted stock units Tax withholding on vesting of restricted stock units Issuance of common stock upon the exercise of warrants Issuance of common stock under employee stock purchase plan Issuance of common stock and common stock warrants, net of issuance costs
Common stock offered 3,100,000 shares by the company
From June 30, 2023 to September 30, 2023 Issuance of common stock under employee stock purchase plan
From December 31, 2022 to March 31, 2023 Issuance of common stock, net of issuance costs Issuance of common stock under employee stock purchase plan Issuance of common stock and common stock warrants, net of issuance costs
Common stock offered 7,220,217 shares by the company
From December 31, 2021 to December 31, 2022 Issuance of common stock, net of issuance costs Issuance of common stock under employee stock purchase plan Issuance of common stock and common stock warrants, net of issuance costs Vesting of restricted stock units
From June 30, 2022 to September 30, 2022 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock under employee stock purchase plan
From March 31, 2022 to June 30, 2022 Issuance of common stock and common stock warrants, net of issuance costs
1.Common stock offered by 4,629,630 shares of common stock. 2.The number of shares of common stock to be outstanding after this offering set forth above is based on 15,895,637 shares of common stock outstanding as of December 31, 2021.
From December 31, 2021 to March 31, 2022 Issuance of common stock under employee stock purchase plan
From December 31, 2020 to December 31, 2021 Issuance of common stock, net of issuance costs Issuance of common stock for exercise of warrants Vesting of restricted stock units
From June 30, 2021 to September 30, 2021 Issuance of common stock upon exercise of warrants
From March 31, 2021 to June 30, 2021 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock upon exercise of warrants, net of offering costs
From December 31, 2020 To March 31, 2021 Issuance of common stock upon exercise of warrants
from December 31, 2019 to December 31, 2020 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock for exercise of warrants, net of offering costs Issuance of common stock upon exercise of pre-funded warrants
1.Common Stock offered 2,320,000 shares. 2.The number of shares of Common Stock that will be outstanding after this offering is based on 9,461,978 shares of Common Stock outstanding as of September 30, 2020.
From June 30, 2020 to September 30, 2020 Issuance of common stock and common stock warrants, net of issuance costs
From December 31, 2019 to March 13, 2020 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock upon exercise of pre-funded warrants
from December 31, 2018 to December 31, 2019 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock for exercise of warrants, net of offering costs Issuance of common stock upon exercise of pre-funded warrants Issuance of common stock upon vesting of restricted stock units
from June 30, 2019 to November 8, 2019 Issuance of common stock upon exercise of warrants, net of offering costs Issuance of common stock upon exercise of pre-funded warrants Issuance of common stock upon vesting of restricted stock units. Trading of the Company’s common stock on The Nasdaq Capital Market will continue, on a split-adjusted basis, with the opening of the markets on Friday, November 8, 2019, under the existing ticker symbol “SLS” but with a new CUSIP number 81642T 209. The reverse stock split reduces the number of shares of the Company’s common stock outstanding from approximately 228 million pre-reverse split shares to approximately 4.6 million post-reverse split shares.
from March 31, 2019 to June 30, 2019 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock upon exercise of warrants, net of offering costs Issuance of common stock upon exercise of pre-funded warrants
from December 31, 2018 to March 31, 2019 Issuance of common stock upon exercise of warrants, net of offering costs
from December 31, 2017 to December 31, 2018 Issuance of Series A convertible preferred stock, net of offering costs Conversion of Series A convertible preferred stock Issuance of common stock to Series A convertible preferred stockholders under most favored nation provision Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock upon exercise of pre-funded warrants Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with litigation settlements Issuance of common stock upon conversion of promissory notes Issuance of common stock in connection with warrant exchange agreements
from December 31, 2017 to September 30, 2018 Issuance of Series A convertible preferred stock, net of offering costs Conversion of Series A convertible preferred stock Issuance of common stock to Series A convertible preferred stockholders under most favored nation provision Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with litigation settlements Issuance of common stock upon conversion of promissory notes Issuance of common stock in connection with warrant exchange agreements Issuance of common stock upon exercise of pre-funded warrants
From December 31, 2017 to June 30, 2018 Issuance of Series A convertible preferred stock, net of offering costs Conversion of Series A Convertible Preferred Stock Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with litigation settlements Issuance of common stock upon conversion of promissory notes Issuance of common stock in connection with warrant exchange agreements
From December 31, 2017 to March 31, 2018 Issuance of Series A convertible preferred stock, net of offering costs Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with warrant exchange agreements
from December 31, 2016 to January 2, 2018 Shares issued in connection with amendments to MSK license Shares issued upon conversion of 2015 Shareholder Notes and accrued interest Sale of common shares to related parties Shares issued in connection with settlement of related party payables Shares issued upon the acceleration of restricted stock units Shares issued upon cancellation of Equilibria restricted stock units Shares issued in connection with acquisition of Galena Shares and common stock warrants issued upon conversion of 2015 Sely Note and accrued interest to Equilibria Shares issued to Equilibria for incentive fee payment in connection with the acquisition of Galena Shares issued to MSK for anti-dilution provisions The number of shares issued in the Merger reflects a 1-for-30 reverse stock split of the Registrant’s common stock that was effected on the Closing Date prior to the Merger (the “Reverse Stock Split”).Immediately after the Merger, on a post-Reverse Stock Split basis, there were approximately 5,766,891 million shares of the Registrant’s common stock outstanding, with the former Private SELLAS securityholders owning approximately 67.5% of the Registrant’s fully diluted common stock, with the Registrant’s securityholders immediately prior to the Merger owning the remaining approximately 32.5%.
From December 31, 2016 to September 30, 2017 Issuance of common stock, net of $356 in issuance costs Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with employee stock purchase plan Fair value of common stock issued in exchange for services
From December 31, 2016 to June 30, 2017 Issuance of common stock, net of $356 in issuance costs Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with employee stock purchase plan Fair value of common stock in exchange for services
From December 31, 2016 to March 31, 2017 Issuance of common stock, net of $356 in issuance costs Issuance of common stock as repayment of principal and interest on long-term debt Issuance of common stock in connection with employee stock purchase plan Fair value of common stock in exchange for services
From December 31, 2015 to December 31, 2016 Issuance of common stock Issuance of common stock to satisfy principal and interest on long-term debt Issuance of common stock in connection with settlement of litigation Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options On October 31, 2016, Galena Biopharma, Inc. approved a reverse stock split of its shares of common stock at a ratio of 1-for-20. The reverse stock split will become effective on November 11, 2016 and the Company’s common stock will commence trading on a split-adjusted basis when the market opens on Monday, November 14, 2016.
On October 31, 2016, Galena Biopharma, Inc. approved a reverse stock split of its shares of common stock at a ratio of 1-for-20. The reverse stock split will become effective on November 11, 2016 and the Company’s common stock will commence trading on a split-adjusted basis when the market opens on Monday, November 14, 2016.
From December 31, 2015 to September 27, 2016 Issuance of common stock Issuance of common stock in connection with litigation settlements Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
from December 31, 2015 to June 30, 2016 Issuance of common stock Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
from December 31, 2015 to March 31, 2016 Issuance of common stock Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
from December 31, 2014 to December 31, 2015 Issuance of common stock Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
from December 31, 2014 to September 30, 2015 Issuance of common stock Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
from December 31, 2014 to June 30, 2015 Issuance of common stock Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
from December 31, 2014 to March 31, 2015 Issuance of common stock Issuance of common stock in connection with employee stock purchase plan
from December 31,2013 to December 31,2014 Issuance of common stock Issuance of common stock under milestone achievement Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
From December 31, 2013 to September 30, 2014 Issuance of common stock for milestone payment Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
from December 31, 2013 to June 30, 2014 Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
From December 31, 2013 to March 31, 2014 Issuance of common stock upon exercise of warrants Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
from December 31,2012 to December 31,2013 Issuance of common stock Issuance of common stock upon exercise of warrants Issuance of common stock in settlement of contingent purchase price consideration Issuance of common stock in exchange for services Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
from December 31, 2012 to September 30, 2013 Issuance of common stock Issuance of common stock upon exercise of warrants Issuance of common stock in settlement of contingent purchase price consideration Issuance of common stock in exchange for services Issuance of common stock in connection with employee stock purchase plan Exercise of stock options
from December 31, 2011 to December 31, 2012 Issuance of common stock, net of offering costs of $2,869 Issuance of common stock in exchange for services Issuance of common stock upon the exchange and exercise of warrants including reclassification of $10,843 in warrant liability upon exercise Issuance of common stock in connection with employee stock purchase plan Issuance of common stock upon the exercise of employee stock options Issuance of common stock in settlement of contingent purchase price consideration
from December 31, 2010 to December 31, 2011 Issuance of stock in lieu of cash bonus Issuance of restricted stock units Issuance of common stock for services Issuance of common stock upon exercise of warrants Issuance of common stock in cashless exchange of outstanding warrants Issuance of common stock related to acquisition of Apthera, Inc Issuance of common stock subject to employee termination agreements Issuance of common stock in connection with employee stock purchase plan
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。